We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Embryonic Stem Cells From Adult Cells

By Biotechdaily staff writers
Posted on 31 Aug 2005
Scientists have created a new type of hybrid cell by fusing adult cells with embryonic stem cells in such a way that the embryonic cells reset the genetic clock of the adult cells, turning them back to their embryonic form. More...
When this feat is fully understood, it may lead to genetically tailored treatments for diseases without the need to create or destroy human embryos.

The adult cells used in the experiment came from foreskin and pelvic areas. In their embryonic form, it may be possible to coax them back "into replacement cells and even organs,” said lead author Chad Cowan, a biologist at the Harvard Stem Cell Institute (Boston, MA, USA). For example, normal cells might be made to replace abnormal ones that cause juvenile diabetes or Alzheimer's disease.

The next step is to figure out how an embryonic cell can turn back, or reprogram, the genes of an adult cell. That could take 10 years, suggests Dr. Cowan. In the meantime, research on the use of hybrid cells for helping patients can continue. The quickest way to new treatments is finding a way to remove the embryonic DNA. "That's the primary hurdle in the foot race to find treatments for patients,” observed Kevin Eggan, also of the Harvard Stem Cell Institute.

When all the problems are solved, the Harvard team sees a new source of stem cells produced without the need to create or destroy embryos that some people insist are "alive.” "We will never satisfy all of the ethical objections to using embryonic stem cells,” admits Dr. Cowan, "but we believe that the majority of people will find this technique morally acceptable.” A report on the research was published in the August 26, 2005, issue of Science.




Related Links:
Harvard U.

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Steam Sterilizer
Hi Vac II Line
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.